78 related articles for article (PubMed ID: 1529171)
21. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
Adam Z; Krejcí M; Vorlícek J
Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
[TBL] [Abstract][Full Text] [Related]
22. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
Hino M; Miyazono K; Urabe A; Takaku F
Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
[TBL] [Abstract][Full Text] [Related]
23. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
[TBL] [Abstract][Full Text] [Related]
24. Influence of recombinant human erythropoietin on hematological and hemostatic parameters with special reference to microhemolysis.
Maurin N; Fitzner S; Fritz H; Gladziwa U; H agel J; Stefanidis I
Clin Nephrol; 1995 Mar; 43(3):196-200. PubMed ID: 7774078
[TBL] [Abstract][Full Text] [Related]
25. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
[No Abstract] [Full Text] [Related]
26. Recombinant human erythropoietin (r-HuEPO): quality of life and other considerations.
Tan A
J CANNT; 1990; ():13-4. PubMed ID: 2202375
[No Abstract] [Full Text] [Related]
27. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
[TBL] [Abstract][Full Text] [Related]
28. [Deformability of erythrocytes and heart surgery with extracorporeal circulation].
Bulvas M
Vnitr Lek; 1983 Apr; 29(4):370-6. PubMed ID: 6868410
[No Abstract] [Full Text] [Related]
29. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P
Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
[No Abstract] [Full Text] [Related]
30. [Erythrocyte morphology in anemia after artificial circulation (based on scanning electron microscopic data)].
Krymskiĭ LD; Mozhina AA; Tereshchenko SN
Arkh Patol; 1985; 47(7):46-54. PubMed ID: 4051815
[TBL] [Abstract][Full Text] [Related]
31. The use of recombinant human erythropoietin in a Jehovah's Witness requiring major reconstructive surgery.
Connor JP; Olsson CA
J Urol; 1992 Jan; 147(1):131-2. PubMed ID: 1729504
[TBL] [Abstract][Full Text] [Related]
32. [Chemical structure, biotechnical production and clinical use of recombinant erythropoietin].
Fandrey JK; Jelkmann WE
Z Gesamte Inn Med; 1992 Jun; 47(6):231-8. PubMed ID: 1642021
[TBL] [Abstract][Full Text] [Related]
33. Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis.
Murphy EA; Bell AL; Wojtulewski J; Brzeski M; Madhok R; Capell HA
BMJ; 1994 Nov; 309(6965):1337-8. PubMed ID: 7866082
[No Abstract] [Full Text] [Related]
34. [Effect on the cell-mediated immunity of the recombinant erythropoietin after open heart surgery: preliminary report].
Hisatomi K; Yasunaga H; Isomura T; Hirano A; Yamashita M; Kosuga K; Ohishi K
Nihon Geka Gakkai Zasshi; 1990 Nov; 91(11):1760. PubMed ID: 2277626
[No Abstract] [Full Text] [Related]
35. [Gastrointestinal bleeding as a complication following cardiosurgery performed under extracorporeal circulation].
Brabletz A; Lorkiewicz Z; Wojna J; Porzegowski M
Pol Przegl Chir; 1978 Aug; 50(8):667-70. PubMed ID: 309600
[No Abstract] [Full Text] [Related]
36. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders.
Mittelman M; Floru S; Djaldetti M
Blood; 1992 Aug; 80(3):841-3. PubMed ID: 1638033
[No Abstract] [Full Text] [Related]
37. Recombinant erythropoietin improves the anemia associated with Gaucher's disease.
Rodgers GP; Lessin LS
Blood; 1989 Jun; 73(8):2228-9. PubMed ID: 2730957
[No Abstract] [Full Text] [Related]
38. Erythropoietin: from hematopoiesis to cardioprotection.
van der Meer P; Lipsic E; van Gilst WH; van Veldhuisen DJ
Cardiovasc Drugs Ther; 2005 Jan; 19(1):7-8. PubMed ID: 15883750
[No Abstract] [Full Text] [Related]
39. [The kinds and characteristics of recombinant human erythropoietin].
Morio K; Koide K
Nihon Rinsho; 1991 Dec; 49 Suppl():663-9. PubMed ID: 1808333
[No Abstract] [Full Text] [Related]
40. Non-parametric mixed effects modeling with NPAG: hematopoietic response to erythropoietin in children.
Port RE
Int J Clin Pharmacol Ther; 2004 Mar; 42(3):185-6. PubMed ID: 15049440
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
